EUVIMEDEUVIMED entdecken
Crossref

Cell-Based Assay to Determine Type 3 Secretion System Translocon Assembly in Pseudomonas aeruginosa Using Split Luciferase

Hanling Guo, Emily J Geddes, Timothy J Opperman iD, Alejandro P Heuck iD

ACS Infectious Diseases · 2023

DOI: 10.1021/acsinfecdis.3c00482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von Hanling Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Program in Molecular and Cellular Biology, University of Massachusetts, Amherst, Massachusetts 01003, United States. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, University of Massachusetts Amherst.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multi-drug-resistant Pseudomonas aeruginosa poses a serious threat to hospitalized patients. This organism expresses an arsenal of virulence factors that enables it to readily establish infections and disseminate in the host. The Type 3 secretion system (T3SS) and its associated effectors play a crucial role in the pathogenesis of P. aeruginosa, making them attractive targets for the development of novel therapeutic agents. The T3SS translocon, composed of PopD and PopB, is an essential component of the T3SS secretion apparatus. In the properly assembled translocon, the N-terminus of PopD protrudes into the cytoplasm of the target mammalian cell, which can be exploited as a molecular indicator of functional translocon assembly. In this article, we describe a novel whole-cell-based assay that employs the split NanoLuc luciferase detection system to provide a readout for translocon assembly. The assay demonstrates a favorable signal/noise ratio (13.6) and robustness (Z' = 0.67), making it highly suitable for high-throughput screening of small-molecule inhibitors targeting T3SS translocon assembly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPseudomonas InfectionsAnimalsHumansBacterial ProteinsType III Secretion SystemsMammals

Stichwörter der Autor:innen

NanoLucP. aeruginosaT3SShigh-throughput screeningsplit luciferase assaytranslocon

Substanzen

Bacterial ProteinsType III Secretion Systems

Autor:innen und Institutionen

  • Program in Molecular and Cellular Biology, University of Massachusetts, Amherst, Massachusetts 01003, United States.
  • Microbiotix, Inc., Worcester, Massachusetts 01605, United States.
  • Department of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, Massachusetts 01003, United States.

ORCID-Profile: Timothy J Opperman, Alejandro P Heuck

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • University of Massachusetts Amherst

Zitieren

APA

Guo, H., Geddes, E. J., Opperman, T. J., & Heuck, A. P. (2023). Cell-Based Assay to Determine Type 3 Secretion System Translocon Assembly in Pseudomonas aeruginosa Using Split Luciferase. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.3c00482

Vancouver

Guo H, Geddes EJ, Opperman TJ, Heuck AP. Cell-Based Assay to Determine Type 3 Secretion System Translocon Assembly in Pseudomonas aeruginosa Using Split Luciferase. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.3c00482

BibTeX
@article{Guo2023,
  author = {Guo, Hanling and Geddes, Emily J and Opperman, Timothy J and Heuck, Alejandro P},
  title = {Cell-Based Assay to Determine Type 3 Secretion System Translocon Assembly in Pseudomonas aeruginosa Using Split Luciferase},
  journal = {ACS Infectious Diseases},
  year = {2023},
  doi = {10.1021/acsinfecdis.3c00482}
}
Kostenlos starten →